Skip to content

Based on the theory of meridians and tendons, edge-needle release in the treatment of combined exercise in the legacy of facial paralysis: a prospective multicenter randomized controlled study

Based on the theory of meridians and tendons, edge-needle release in the treatment of combined exercise in the legacy of facial paralysis: a prospective multicenter randomized controlled study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055435
Enrollment
Unknown
Registered
2022-01-09
Start date
2021-12-31
Completion date
Unknown
Last updated
2023-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial paralysis with joint movement

Interventions

Sponsors

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria for facial paralysis, and the onset of facial paralysis for more than 3 months and joint movement on the side of facial paralysis. 2. The facial synovial movement of the patients was assessed as mild or above by the Sunnybrook (Toronto) facial nerve assessment system. 3. Aged between 18 and 80 years. 4. Normal consciousness, able to express their own opinions correctly, and able to cooperate with the treatment. 5. Those who voluntarily participated in this study and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Joint exercise is caused by facial nerve injury other than Bell's palsy and Hunt syndrome due to jaw and neck trauma, brain trauma, tumor surgery, etc. 2. Only manifested as primary and secondary hemifacial spasm. 3. Those with primary and secondary trigeminal nerve pain. 4. Those with disturbance of consciousness and unstable condition. 5. Combined with serious primary diseases such as cardiovascular, liver, kidney, lung and hematopoietic system, the disease has not been effectively controlled. 6. Pregnancy and puerperium. 7. Those with fainting needles, facial skin allergies and infections. 8. Those who have recently taken central muscle relaxation drugs, neurobotulinum toxin, alcohol or other nerve or motor point block therapy. 9. Other clinical investigators are being accepted.

Design outcomes

Primary

MeasureTime frame
Sunnybrook Facial Grading System;

Secondary

MeasureTime frame
House–Brackmann Facial Nerve Grading System;The Facial Disability Index (FDI) Scale;Self-rating Depression Scale;Self-rating Anxiety Scale;Facial asymmetry;

Countries

China

Contacts

Public ContactLi Dehua

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine

si_ff@163.com+86 18980079361

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026